Related Experiment Video
Updated: Jun 21, 2026

Preparation of Stable Bicyclic Aziridinium Ions and Their Ring-Opening for the Synthesis of Azaheterocycles
Published on: August 22, 2018
Recent progress in enzymatic resolution and desymmetrization of pharmaceuticals and their intermediates
1DuPont Pharmaceutical Company, Chemical Process Research & Development, DuPont Experimental Station, E336/147 Wilmington, DE 19880-0336, USA. jaan.a.pesti@dupontpharma.com
Abstract:
The literature is surveyed from mid-1998 through to August 2000 for examples of the resolution or desymmetrization of existing/potential pharmaceutical entities and pharmaceutical intermediates, and of chiral building blocks for pharmaceutical manufacture. Examples of commercial interest are included with new developments in the art of resolution.
Related Concept Videos
Racemic Mixtures and the Resolution of Enantiomers
Phase I Reactions: Hydrolytic Reactions
An important hydrolytic reaction is ester hydrolysis. Ester bonds, often found in prodrugs, are broken down, increasing the solubility of drugs like aspirin and lidocaine for more straightforward elimination. Amide hydrolysis is another critical reaction, targeting amide bonds prevalent...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Downstream Processing
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
Drug Biotransformation: Overview

